Lai Gang 4

What Happened

• Lai Gang, CEO of Universe Pharmaceuticals (UPC), was granted two equity awards on May 7, 2026 totaling 84,500 ordinary shares (71,890 + 12,610). No per-share price or cash consideration is reported for these awards (transaction code A = award/grant). The grants are made under the Issuer's 2026 Equity Incentive Plan and are described as consideration for past services.

Key Details

• Transaction date: May 7, 2026. Filing date: May 21, 2026 (filed 14 days after the transaction).
• Price: Not reported (N/A) — these are equity awards, not open-market purchases or sales.
• Post-transaction beneficial ownership: The Form 4 does not list total shares owned by Lai after these grants. The filing does note 3,467 Class B ordinary shares are held by Sununion Holding Group Limited, a BVI entity 100% owned and controlled by Lai (footnote).
• Footnotes: F1 — awards under the 2026 Equity Incentive Plan and subject to an award agreement dated May 5, 2026; F2 — discloses 3,467 Class B shares held by the reporting person’s controlled entity (Sununion Holding Group Limited).
• Timeliness: The report was filed on May 21 for May 7 transactions, which is later than the typical two-business-day Form 4 deadline and may warrant correction or attract SEC follow-up.

Context

• These were equity awards (grant/award), not purchases or sales — awards compensate or incentivize executives and do not by themselves indicate immediate buying or selling in the market.
• The filing notes the grants are exempt under Rule 16b-3, which is the usual safe harbor for compensatory awards to insiders.